Current Assets Cambiamento Data
AstraZeneca USD 22.5B 338M 2023-09
Canopy Growth CAD 493.7M 389.53M 2023-09
Gilead Sciences USD 16.45B 474M 2023-12
Pacira USD 509.99M 62.74M 2023-12
Perrigo USD 2.77B 7.7M 2023-09
Prestige Brands USD 393.79M 5.59M 2023-12
Roche Holding CHF 30.98B 2.84B 2023-06
Supernus Pharmaceuticals USD 493.11M 43.75M 2023-12



Novartis Attività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2024.